During a nationwide outbreak of healthcare-associated infections of an antibiotic-resistant bacteria, an Israeli hospital traced repeated infections of patients in its intensive care unit (ICU) to an unexpected source--sink traps, according to a study published today in Infection Control & Hospital Epidemiology.
"Understanding the source of these resistant bacteria and how they were being spread was essential to effectively intervening and preventing the further spread," said Gili Regev-Yochay, MD, lead author of the study and Director of the Infection Prevention & Control Unit at Sheba Medical Center at Tel HaShomer in Israel. "While we were unable to prevent the sink traps from being colonized, by changing our behavior associated with the sinks we have prevented the spread of these infections."
From January 2016 to May 2017, 32 cases of OXA-48 Carbapenemase-producing Enterobacteriaceae (CPE) were detected, with all but the first two traced to the same bacteria. Most cases were initially detected through routine screening, 11 developed clinical infections, and three deaths were directly attributed to these infections.
The infection control team work closely with staff from the ICU--including clinicians, cleaning staff, a pharmacist and social worker--to systematically trace the source of CPE contamination to 22 sinks in the 16-bed ICU. Frequent decontamination of the sinks using different techniques only temporarily eliminated bacteria. However, decontamination combined with the adoption of sink contamination prevention guidelines eliminated new infections.
CPE is usually spread from one patient to another through contact with staff or objects moved from room to room. But increasingly, hospital water has been recognized as a source of carbapenem-resistant organisms, the authors said. Running water from a sink can create an aerosol contamination of bacteria that can spread at least a meter from the sink during handwashing, authors said. Effective guidelines used by researchers included limited use of sinks in patient rooms, only using sinks for hand washing when necessary, a ban on clinical waste disposal in sinks, and avoiding storage of materials near the sinks.
Initial sink decontamination efforts included routine cleaning with bleach and later with acetic-acid, but weekly sampling showed that these efforts were effective for only a short time. In one room with a contaminated sink, a self-disinfecting sink trap was installed, but the trap was removed after a patient in a neighboring room acquired an infection from the same bacteria that was detected again in the new trap.
Reference: Gili Regev-Yochay, MD, MS; Gill Smollen, MD; Ilana Tal, RN; Nani Pinas Zade, RN; Yael Haviv, MD, Valery Nudelman, RN; Ohad Gal-Mor, PhD; Hanaa Jaber, BsC;, Eyal Zimlichman, MD; Nati Keller, MD, and Galia Rahav, MD. "Sink-traps as the Source of Transmission of Serratia marcescens-OXA48 in an Intensive Care Unit" Web (October 4, 2018).
Source: Society for Healthcare Epidemiology of America (SHEA)
Comprehensive Strategies in Wound Care: Insights From Madhavi Ponnapalli, MD
November 22nd 2024Madhavi Ponnapalli, MD, discusses effective wound care strategies, including debridement techniques, offloading modalities, appropriate dressing selection, compression therapy, and nutritional needs for optimal healing outcomes.
The Leapfrog Group and the Positive Effect on Hospital Hand Hygiene
November 21st 2024The Leapfrog Group enhances hospital safety by publicizing hand hygiene performance, improving patient safety outcomes, and significantly reducing health care-associated infections through transparent standards and monitoring initiatives.
Managing Multimorbidity and Polypharmacy in HIV: Insights From Michelle S. Cespedes, MD, MS
November 20th 2024Michelle S. Cespedes, MD, MS, discusses the challenges of managing multimorbidity and polypharmacy in HIV treatment, emphasizing patient education, evolving guidelines, and real-world insights from the REPRIEVE study.
Longhorn Vaccines and Diagnostics to Showcase Breakthrough Vaccine Data at IDWeek 2024
November 19th 2024Longhorn Vaccines and Diagnostics revealed promising data on universal influenza vaccine LHNVD-110 and AMR sepsis vaccine LHNVD-303 at IDWeek 2024, addressing critical global health challenges.